SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : First Venture Capital -A major player in Vision Correction

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotechboy13 who wrote (1)2/4/1999 5:52:00 PM
From: The Coz   of 21
 
Here's some more data for ya !

FVC FIRST VENTURE CAPITAL CORP.
450 - 999 West Hastings Street
Vancouver, B.C.V6C 2W2
Tel: (604) 683-3070

FOR IMMEDIATE RELEASE

Trading Symbol - FVC.VSE
News Release No. 04

NEWS RELEASE

Vancouver, B.C., February 01, 1999 -- FVC First Venture Capital Corp. (the Company) advises that it has negotiated a private placement of 300,000 common shares at a price of $2.10 per share. The placement is being completed with four eastern doctors working with Lasik Vision Canada Inc. (Lasik) and is contingent upon the Company completing the acquisition of Lasik.

The private placement, subject to regulatory approval is non-brokered, has no finders fee or commission payable, has no warrrants and/or rights attached and will be subject to a one year hold period.

FVC FIRST VENTURE CAPITAL CORP.

signed Stuart R. Ross

Stuart R. Ross, Director

For further information please contact:
Waterfront Communications, Kelly Lendvoy or Dan Evans (Tel: (604) 683-3070)

THE VANCOUVER STOCK EXCHANGE NOR ANY OTHER REGULATORY BODY HAS REVIEWED AND THEREFORE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext